A cohort study published in The Journal of Urology (2015) examined the incidence of prostate cancer in hypogonadal men receiving long-term testosterone therapy. Analyzing data from 1,023 patients, the study found no significant increase in prostate cancer risk, with 11 cases of prostate cancer diagnosed over the follow-up period. The
